MGO One Seven’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.88M | Sell |
41,185
-720
| -2% | -$50.3K | 0.09% | 246 |
|
2025
Q1 | $3.08M | Buy |
41,905
+3,968
| +10% | +$292K | 0.12% | 186 |
|
2024
Q4 | $2.49M | Buy |
37,937
+21,977
| +138% | +$1.44M | 0.1% | 236 |
|
2024
Q3 | $1.24M | Sell |
15,960
-654
| -4% | -$51K | 0.05% | 352 |
|
2024
Q2 | $1.3M | Buy |
16,614
+1,607
| +11% | +$125K | 0.06% | 319 |
|
2024
Q1 | $1.02M | Buy |
15,007
+2,078
| +16% | +$141K | 0.05% | 343 |
|
2023
Q4 | $871K | Buy |
12,929
+6,917
| +115% | +$466K | 0.05% | 353 |
|
2023
Q3 | $407K | Buy |
6,012
+2,179
| +57% | +$148K | 0.03% | 506 |
|
2023
Q2 | $274K | Sell |
3,833
-263
| -6% | -$18.8K | 0.03% | 629 |
|
2023
Q1 | $284K | Buy |
4,096
+479
| +13% | +$33.2K | 0.02% | 689 |
|
2022
Q4 | $245K | Buy |
+3,617
| New | +$245K | 0.02% | 617 |
|
2022
Q3 | – | Sell |
-5,033
| Closed | -$333K | – | 718 |
|
2022
Q2 | $333K | Sell |
5,033
-10,051
| -67% | -$665K | 0.05% | 432 |
|
2022
Q1 | $1M | Sell |
15,084
-96
| -0.6% | -$6.37K | 0.11% | 210 |
|
2021
Q4 | $884K | Buy |
15,180
+572
| +4% | +$33.3K | 0.09% | 249 |
|
2021
Q3 | $911K | Buy |
+14,608
| New | +$911K | 0.12% | 218 |
|
2021
Q2 | – | Sell |
-9,691
| Closed | -$481K | – | 592 |
|
2021
Q1 | $481K | Sell |
9,691
-601
| -6% | -$29.8K | 0.08% | 305 |
|
2020
Q4 | $532K | Sell |
10,292
-1,519
| -13% | -$78.5K | 0.11% | 243 |
|
2020
Q3 | $644K | Buy |
+11,811
| New | +$644K | 0.15% | 172 |
|
2020
Q1 | – | Sell |
-9,523
| Closed | -$474K | – | 403 |
|
2019
Q4 | $474K | Buy |
9,523
+4,383
| +85% | +$218K | 0.12% | 227 |
|
2019
Q3 | $229K | Sell |
5,140
-2
| -0% | -$89 | 0.07% | 370 |
|
2019
Q2 | $212K | Buy |
+5,142
| New | +$212K | 0.07% | 360 |
|
2019
Q1 | – | Sell |
-3,193
| Closed | -$121K | – | 511 |
|
2018
Q4 | $121K | Buy |
+3,193
| New | +$121K | 0.05% | 413 |
|
2018
Q1 | $581K | Sell |
16,608
-1,277
| -7% | -$44.7K | 0.27% | 103 |
|
2017
Q4 | $621K | Buy |
+17,885
| New | +$621K | 0.29% | 92 |
|